Atherosclerosis of aorta
Methodology & AI Transparency ⓘ
Atherosclerosis of aorta Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code I70.0 in Blood Pressure, Atherosclerosis of aorta requires vascular stiffness assessment [Atherosclerosis of aorta I70.0] so specialists can calibrate treatment intensity against Urine Albumin-to-Creatinine Ratio [Atherosclerosis of aorta I70.0] benchmarks.
- 2 Real-world patient consensus: Clinical coding for Atherosclerosis of aorta uses ICD-10 I70.0 across Blood Pressure specialty care.
- 3 Typical cash cost range: Differential triage of Atherosclerosis of aorta (I70.0) utilizes vascular stiffness assessment [Atherosclerosis of aorta I70.0].
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Atherosclerosis of aorta (I70.0): Urine Albumin-to-Creatinine Ratio [Atherosclerosis of aorta I70.0] & Home Seated Blood in Atherosclerosis of aorta (I70.0: Pressure) (< 120/75 mmHg (I70.0)).
Ask our AI Specialists anything about Atherosclerosis of aorta
What Is Atherosclerosis of aorta?
Cataloged under federal diagnostic code I70.0 in Blood Pressure, Atherosclerosis of aorta requires vascular stiffness assessment [Atherosclerosis of aorta I70.0] so specialists can calibrate treatment intensity against Urine Albumin-to-Creatinine Ratio [Atherosclerosis of aorta I70.0] benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Atherosclerosis of aorta (I70.0) alters blood pressure homeostasis through intimal-medial vascular remodeling [Atherosclerosis of aorta I70.0]; clinical remission targets Home Seated Blood in Atherosclerosis of aorta (I70.0: Pressure) within < 120/75 mmHg (I70.0).
Common Symptoms & Clinical Signs
- • Presentation of Atherosclerosis of aorta (I70.0): morning occipital headache, in Atherosclerosis of aorta (I70.0: pulsatile tinnitus, or)
- • Secondary Atherosclerosis of aorta clinical sign: calf cramping or in Atherosclerosis of aorta (I70.0: claudication triggered by)
- • Symptom flares in Atherosclerosis of aorta correlating with Urine Albumin-to-Creatinine Ratio [Atherosclerosis of aorta I70.0] deviation outside < 15 mg/g (I70.0)
- • Functional blood pressure impact requiring vascular stiffness assessment [Atherosclerosis of aorta I70.0] evaluation (I70.0)
Atherosclerosis of aorta Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I70.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Atherosclerosis of aorta I70.0] | < 15 mg/g (I70.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Atherosclerosis of aorta (I70.0: Pressure) | < 120/75 mmHg (I70.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Atherosclerosis of aorta I70.0] | 1.00 – 1.30 (I70.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Atherosclerosis of aorta
Treatment selection for Atherosclerosis of aorta depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Atherosclerosis of aorta)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Heart and blood vessel outcomes in high-risk hypertensive patients stratified by: What a 8,126-Participant Study Found Older high-risk patients with high blood pressure and reduced GFR are more likely to develop CHD than to develop ESRD. Annals of internal medicine • 2006-02-07 • Randomized Controlled Trial | N = 8,126 | 96/100 | PMID 16461961 ↗ |
| New Insights on Benefits and safety of Actovegin in the treatment of intermittent claudication:: What a 366-Participant Study Found The results of this 12-week course of Actovegin demonstrated its superiority over placebo in the increase in ICD and ACD at weeks 2, 12 and 24 from the start of treatment. International angiology : a journal of the International Union of Angiology • 2022-10-15 • Phase III Randomized Trial | N = 366 | 93/100 | PMID 36264097 ↗ |
| Can This Approach Help? Inside the Latest Research on Results of the MACiTEPH study of macitentan for the treatment of inoperable or MACiTEPH was discontinued for futility, as no treatment effect on 6MWD (primary endpoint) was observed. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2026-03-15 • Phase III Randomized Trial | N = 127 | 88/100 | PMID 41297734 ↗ |
| Can This Approach Help? Inside the Latest Research on Renoprotective effect of esaxerenone independent of blood pressure lowering: a These results confirm that esaxerenone has a direct UACR-lowering effect independent of BP lowering and that its magnitude is much larger than that of the BP-dependent effect. Hypertension research : official journal of the Japanese Society of Hypertension • 2023-02-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 36100672 ↗ |
| Can This Approach Help? Inside the Latest Research on Alirocumab on endothelial function and coronary atherosclerosis in heart attack: Among patients with AMI, the addition of alirocumab did not result in further improvement of FMD as compared to 52 weeks secondary preventative medical therapy including high-intensity statin therapy. Atherosclerosis • 2024-05-15 • Randomized Controlled Trial | N = 68 | 88/100 | PMID 38513436 ↗ |
Atherosclerosis of aorta Patient Community & “People Like Me” Threads
Filter Atherosclerosis of aorta community threads and patient logs by age, biological sex, dosage, and treatment duration.